Jerry Shevitz

466 total citations
17 papers, 397 citations indexed

About

Jerry Shevitz is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Jerry Shevitz has authored 17 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jerry Shevitz's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Jerry Shevitz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Jerry Shevitz collaborates with scholars based in United States and Italy. Jerry Shevitz's co-authors include Shui‐on Leung, David M. Goldenberg, Lisa B. Shih, Lawrence C. Swayne, Arnold S. Dion, Thomas M. Behr, Robert M. Sharkey, H. J. Hansen, Hans J. Hansen and Malik E. Juweid and has published in prestigious journals such as Journal of Clinical Investigation, Nature Biotechnology and Molecular Immunology.

In The Last Decade

Jerry Shevitz

17 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry Shevitz United States 9 263 150 123 98 57 17 397
E T Verghese United Kingdom 6 43 0.2× 186 1.2× 65 0.5× 110 1.1× 20 0.4× 6 429
Vinicius S. Saraiva Canada 13 83 0.3× 160 1.1× 18 0.1× 64 0.7× 50 0.9× 26 392
Gianni Capalbo Germany 11 56 0.2× 245 1.6× 33 0.3× 185 1.9× 34 0.6× 15 431
Qungang Shan China 13 141 0.5× 83 0.6× 20 0.2× 59 0.6× 38 0.7× 24 432
Ying Deng China 12 126 0.5× 136 0.9× 25 0.2× 71 0.7× 17 0.3× 58 457
Xibao Yu China 12 55 0.2× 384 2.6× 40 0.3× 155 1.6× 130 2.3× 19 658
Blaž Grošelj Slovenia 12 42 0.2× 296 2.0× 31 0.3× 131 1.3× 23 0.4× 19 439
Eva Dahlén Sweden 7 96 0.4× 112 0.7× 23 0.2× 199 2.0× 407 7.1× 10 656
Brandon M. Bordeau United States 10 201 0.8× 101 0.7× 10 0.1× 256 2.6× 61 1.1× 15 380

Countries citing papers authored by Jerry Shevitz

Since Specialization
Citations

This map shows the geographic impact of Jerry Shevitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Shevitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Shevitz more than expected).

Fields of papers citing papers by Jerry Shevitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Shevitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Shevitz. The network helps show where Jerry Shevitz may publish in the future.

Co-authorship network of co-authors of Jerry Shevitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Shevitz. A scholar is included among the top collaborators of Jerry Shevitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Shevitz. Jerry Shevitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
LaPorte, Thomas L., et al.. (1996). Long term shear effects on a hybridoma cell line by dynamic perfusion devices. Bioprocess and Biosystems Engineering. 15(1). 1–7. 2 indexed citations
2.
Leung, Shui‐on, David M. Goldenberg, Arnold S. Dion, et al.. (1995). Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2. Molecular Immunology. 32(17-18). 1413–1427. 91 indexed citations
3.
Sharkey, Robert M., Malik Juweid, Jerry Shevitz, et al.. (1995). Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies.. PubMed. 55(23 Suppl). 5935s–5945s. 73 indexed citations
4.
LaPorte, Thomas L., Jerry Shevitz, Youngsun Kim, & Shaw S. Wang. (1995). Hybridoma perfusion system using a sedimentation device. Biotechnology Techniques. 9(11). 837–842. 1 indexed citations
5.
Losman, Michele J., Shui‐on Leung, Lisa B. Shih, et al.. (1995). Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2.. PubMed. 55(23 Suppl). 5978s–5982s. 8 indexed citations
6.
Juweid, Malik E., Robert M. Sharkey, Thomas M. Behr, et al.. (1995). Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.. PubMed. 55(23 Suppl). 5899s–5907s. 99 indexed citations
7.
Leung, Shui‐on, Jerry Shevitz, Arnold S. Dion, et al.. (1994). Chimerization of LL2, a Rapidly Internalizing Antibody Specific for B Cell Lymphoma. Hybridoma. 13(6). 469–476. 26 indexed citations
8.
Losman, Michele J., Shui‐on Leung, Jerry Shevitz, et al.. (1994). DEVELOPMENT AND EVALUATION OF THE SPECIFICITY OF A RAT MONOCLONAL ANTI-IDIOTYPE ANTIBODY, WN, TO AN ANTI-B-CELL LYMPHOMA MONOCLONAL ANTIBODY, mLL2. Journal of Immunotherapy. 16(2). 171–171. 1 indexed citations
9.
Sharkey, Robert M., David M. Goldenberg, Malik E. Juweid, et al.. (1994). TREATMENT OF NON-HODGKINʼS LYMPHOMA (NHL) WITH LL2, AN ANTI-CD 22 MONOCLONAL ANTIBODY. Journal of Immunotherapy. 16(2). 160–160. 1 indexed citations
10.
Sharkey, Robert M., Malik E. Juweid, Jerry Shevitz, et al.. (1994). PRECLINICAL AND CLINICAL EVALUATION OF A CDR-GRAFTED (HUMANIZED) ANTI-CARCINOEMBRYONIC ANTIGEN (CEA) MONOCLONAL ANTIBODY (MAb). Journal of Immunotherapy. 16(2). 164–164. 1 indexed citations
11.
Chen, Yi‐Kai, Thomas L. LaPorte, Shaw S. Wang, & Jerry Shevitz. (1992). High density culture of HeLa cells in a CelliGen perfusion system. Cytotechnology. 8(1). 85–88. 2 indexed citations
12.
Shevitz, Jerry, et al.. (1990). Production of viral vaccines in stirred bioreactors.. PubMed. 14. 1–35. 5 indexed citations
13.
Shevitz, Jerry, et al.. (1989). Stirred tank perfusion reactors for cell propagation and monoclonal antibody production.. PubMed. 11. 81–106. 3 indexed citations
14.
Shevitz, Jerry, et al.. (1989). Increased Biomass Production in a Benchtop Fermentor. Nature Biotechnology. 7(11). 1178–1181. 14 indexed citations
15.
Shevitz, Jerry, et al.. (1987). A perfusion system for antibody production by shear-sensitive hybridoma cells in a stirred reactor. Biotechnology Techniques. 1(3). 28 indexed citations
16.
Shevitz, Jerry, C. S. P. Jenkins, & Victor B. Hatcher. (1986). Fibronectin synthesis and degradation in human fibroblasts with aging. Mechanisms of Ageing and Development. 35(3). 221–232. 19 indexed citations
17.
Shefer, Sarah, Susan Hauser, Gerald Salen, et al.. (1984). Comparative effects of cholestanol and cholesterol on hepatic sterol and bile acid metabolism in the rat.. Journal of Clinical Investigation. 74(5). 1773–1781. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E T Verghese Breakdown of academic impact, for papers by Vinicius S. Saraiva Breakdown of academic impact, for papers by Gianni Capalbo Breakdown of academic impact, for papers by Qungang Shan Breakdown of academic impact, for papers by Ying Deng Breakdown of academic impact, for papers by Xibao Yu Breakdown of academic impact, for papers by Blaž Grošelj Breakdown of academic impact, for papers by Eva Dahlén Breakdown of academic impact, for papers by Brandon M. Bordeau
Rankless by CCL
2026